Pierre Fabre CDMO

  • Booth: 357

Pierre FABRE CDMO proposes its international partners a full service, from clinical development to commercial production in the following fields of expertises: manufacturing of APIs (in particular natural products, animal/plant extracts, cytotoxic agents), supercritical CO2 formulation, production and packaging of pharmaceutical lozenges (and other dry forms) and fill & finish of injectable products (in vials or prefilled syringes), including conventional cytotoxic and biotechnology products (antibodies, ADC, vaccines) with large lyophilisation capacity.We commit to provide innovative solutions in compliance with worldwide quality standards. Our production sites meet the highest regulatory requirements and have been approved by drug administration authorities (EMA, FDA, PMDA, ANVISA…).